Veeda Clinical Research Pvt Ltd
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for enhanced drug developments to facilitate better patient treatments.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Medscape presents Digital Health in Practice: Impact & Insights at Reuters #Pharma2020
Press Releases | September 30, 2022 | Medscape Education
Medscape will be attending the Reuters Events Pharma 2022 conference from 11 – 13 October at Nice Acropolis Convention Center in Nice, France. The Medscape Professional Network will connect with...
Overcoming Patient Recruitment Challenges in Rare Disease Trials
Videos and Podcasts | September 30, 2022 | Innovative Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...
A powerful care platform connects medical professionals and patients
Press Releases | September 30, 2022 | Medscape Education
Education platforms that disseminate the latest advances in cardiovascular medicine to cardiologists, physicians and healthcare professionals are helping deliver better outcomes for heart patients.
Modern Medical Affairs: How to Leverage Tech and Data as an MSL
Videos and Podcasts | September 29, 2022 | Impetus Digital
Dr. Luca Dezzani, VP of US Oncology Medical Affairs at Johnson & Johnson, explores innovation in Medical Affairs, new technologies for data dissemination and medical education, how to engage with...
The Creative Engagement Group appoints Tom Griffiths from Saatchi & Saatchi Wellness as Strategy and Planning Director
Press Releases | September 29, 2022 | The Creative Engagement Group
The Creative Engagement Group has appointed experienced healthcare and digital strategist Tom Griffiths.
Is communication failing us?
White Papers and Resources | September 29, 2022 | Page & Page Health
Compelling people to care in a world oversaturated with news and information
Are your field teams ready to excel in the new era?
White Papers and Resources | September 29, 2022 | The Creative Engagement Group
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs.
The Sofa Sessions – The Sixth Page
Videos and Podcasts | September 29, 2022 | Page & Page Health
5 Healthcare Marketing Blunders | How To Avoid Them.
White Papers and Resources | September 29, 2022 | The Good Ideas Group
Here are 5 healthcare marketing blunders and how best to avoid them.
Design Trends We’ve Seen In 2022
White Papers and Resources | September 29, 2022 | The Good Ideas Group
Our graphic designer Isla takes a deep dive into the graphic design trends we’ve seen in 2022 and what to expect throughout 2023 and beyond.